GHK-Cu is the copper tripeptide that shows up in every anti-aging skin pitch. The marketing copy makes it sound like a miracle. The actual published research is more specific. The compound does four documented things. Not eight. Not twelve. Four.
This piece walks through those four pathways in plain English, what each one means for skin and connective tissue research, the standard cycle structure, and where the marketing claims stop matching the literature.
What GHK-Cu is
GHK-Cu is a three-amino-acid peptide (glycine, histidine, lysine) bound to a copper ion in a one-to-one complex. The sequence already exists in human plasma at micromolar levels, where it appears to act as a copper carrier. That level drops measurably across the human lifespan, from about 200 ng/mL in young adults to roughly 80 ng/mL by age 60. That decline is the foundation for the research interest in supplemental administration.
The four documented effects
1. Copper delivery
The peptide is a copper carrier. Many enzymes in skin and connective tissue need copper to function, including lysyl oxidase (which crosslinks collagen) and superoxide dismutase (an antioxidant enzyme). GHK-Cu drops copper at tissue sites where those enzymes operate. The bare peptide without copper is less active in published research models, which tells you the copper is doing real work, not riding along.
2. Collagen and elastin signaling
In dermal research models, GHK-Cu has been reported to up-regulate collagen and elastin synthesis. The effect appears at concentrations in the micromolar range, matching what plasma levels look like in younger adults. This is the pathway most cited in the topical cosmetic literature.
3. Broad gene expression modulation
Transcriptomic studies (research that looks at which genes are switched on and off) have reported that GHK-Cu modulates hundreds of genes at the application site. The affected pathways span wound research, antioxidant defense, and tissue remodeling. This is the most surprising finding in the literature: a three-amino-acid peptide influencing that many gene expression patterns.
4. Antioxidant pathway support
Reported support for superoxide dismutase and other antioxidant enzymes in experimental models. This is mechanistically consistent with the copper delivery pathway, since superoxide dismutase is itself a copper-dependent enzyme.
What does the GHK-Cu research signal cover?
Frequently cited research targets in the published GHK-Cu literature:
- Skin research models (wound, aging, photo-aging)
- Hair research models
- Connective tissue research models
- Lung research models
- Bone research models
Topical GHK-Cu has a longer cosmetic research history. Injectable subQ administration is more recent and has a smaller human research base, mostly observational. Phase 3 registration trials are not in the published record.
What is the standard GHK-Cu research cycle structure?
| Route | Cycle | Dose | Frequency |
|---|---|---|---|
| Subcutaneous | 4 to 8 weeks | 1 to 2 mg | Daily |
| Subcutaneous (low-dose maintenance) | Ongoing pulses | 0.5 to 1 mg | Every other day |
| Topical | Continuous | 0.1 to 1 percent formulation | Once or twice daily |
| Stacked (with BPC-157 + TB-500) | 4 to 6 weeks | 1 mg subQ | Daily, paired with stack |
What are the GHK-Cu side effects from the literature?
- Injection site response. Mild redness or tenderness at the subQ site, usually gone within hours.
- Local discoloration. A small minority of researchers report a short-lived bluish tint at the injection site, from the copper complex. Goes away on its own.
- Mild headache. Uncommon. Usually resolves with extra water.
- Topical irritation. Some researchers report mild irritation on first topical use. Usually settles within 1 to 2 weeks.
Copper buildup is a long-term concern with extended high-dose subQ protocols. That's why most research practice caps continuous dosing at 8 weeks before a wash-out.
How do you reconstitute and store GHK-Cu?
Aion ships GHK-Cu in 50 mg and 100 mg vials. Standard mix for the 50 mg vial: 2 mL of bac water, giving 25 mg per mL, or 250 mcg per insulin syringe unit. A 1 mg dose at that concentration is 4 units. A 2 mg dose is 8 units. Full walk-through in our reconstitution guide.
- Lyophilized, sealed: refrigerated at 2 to 8 C, stable for months
- Lyophilized, long-term: minus 20 C freezer for multi-year storage
- Reconstituted with bac water: refrigerated at 2 to 8 C, keep out of light, 4 to 6 week use window
What researchers track on a GHK-Cu cycle
- Skin quality self-assessment (1 to 10), weekly
- Photographs of the research site (skin, hair, etc.), weekly
- Pain or limitation at any soft-tissue research site, daily
- Sleep quality, daily via wearable
- Resting heart rate, weekly average
What is the GHK-Cu bottom line?
GHK-Cu does four things in the published research. Copper delivery, collagen signaling, gene expression modulation, antioxidant support. Each one has a real literature base. The marketing claims that stretch beyond those four pathways are speculation, not published science.
The dual-route delivery (topical and subQ) and the clean stack compatibility withBPC-157 and TB-500 make it a flexible piece in soft-tissue research protocols. The 4 to 8 week cycle with a wash-out is the operational pattern the literature supports. For the broader connective tissue stack, see /research/bpc-157.